Invasive Fungal Infection Market

Invasive fungal infection refers to the pathological changes and pathophysiological processes of fungi that invade human tissues and blood, and grow and multiply in them, leading to tissue damage, organ dysfunction, and inflammation.
Invasive Fungal Infection Market aims to provide a comprehensive presentation of the global market for Invasive Fungal Infection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Invasive Fungal Infection. Invasive Fungal Infection Market contains market size and forecasts of Invasive Fungal Infection in global, including the following market information:
Global Invasive Fungal Infection Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Invasive Fungal Infection market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Diagnosis Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Invasive Fungal Infection include Cidara Therapeutics, Basilea Pharmaceutica, Pfizer, GlaxoSmithKline, Bayer, Abbott, Merck, Astellas Pharma and F2G, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Invasive Fungal Infection companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Invasive Fungal Infection Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Invasive Fungal Infection Market Segment Percentages, by Type, 2022 (%)
Diagnosis
Treatment
Global Invasive Fungal Infection Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Invasive Fungal Infection Market Segment Percentages, by Application, 2022 (%)
Yeast-like Fungi
Filamentous Fungi
Other
Global Invasive Fungal Infection Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Invasive Fungal Infection Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Invasive Fungal Infection revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Invasive Fungal Infection revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Cidara Therapeutics
Basilea Pharmaceutica
Pfizer
GlaxoSmithKline
Bayer
Abbott
Merck
Astellas Pharma
F2G
Scynexis
Associates of Cape Cod
BioRad
IMMY
Beijing Jinshanchuan
Danna Biological
Zhanjiang A and C Biological
Outline of Major Chapters:
Chapter 1: Introduces the definition of Invasive Fungal Infection, market overview.
Chapter 2: Global Invasive Fungal Infection market size in revenue.
Chapter 3: Detailed analysis of Invasive Fungal Infection company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Invasive Fungal Infection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.